Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Mar 2012
- 492-500 p. digital
Publication Type: Journal Article
1521-0103
10.1124/jpet.111.189365 doi
Animals Azepines--pharmacology Benzimidazoles--pharmacology Blood Pressure--drug effects Dose-Response Relationship, Drug Drug Discovery Male Protein Kinase Inhibitors--pharmacology Rats Rats, Sprague-Dawley Receptors, Adrenergic, alpha-1--metabolism Receptors, Adrenergic, alpha-2--metabolism Ribosomal Protein S6 Kinases, 90-kDa--antagonists & inhibitors